Advice Pool
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Drug Abuse > Preventing Abuse of Prescription Drugs and Pain Medications

Tags

  • regulatory
  • about
  • involved
  • become addicted

  • Links

  • Ebooks -- Self-Publishing Your Way to Internet Success: Part 2 Ebook Formats (PDF)
  • Transport in Dublin and Ireland
  • Inspirational Thought For The Day
  • Advice Pool - Preventing Abuse of Prescription Drugs and Pain Medications

    Relieving pain from a patient while steering clear from the possible addiction to pain killers has become the specific problem health care provider constantly fight. This is the reason why doctors under-prescribe painkillers, because they
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    fear the patients to become addicted to medications such as morphine and codeine. Although these drugs carry a heightened risk of addiction, research has shown that providers' concerns that patients will become addicted to pain medicatio
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    n are mostly unfounded: Most patients who are prescribed opioids for pain, even those undergoing long-term therapy, do not develop an addiction.

    The few patients who do develop such an addiction usually have a history of psychological pr
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    oblems or prior substance abuse. In fact, studies show that the potential to abuse opioid medications is usually low in healthy, drug-free volunteers. One study found that only 4 out of about 12,000 patients who were given opioids for acu
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    te pain became addicted. In a study of 38 patients suffering from acute pain, most of whom received opioids for 4 to 7 years, 2 had become addicted, and both held histories of drug abuse.

    The issue of inadequate prescription of opioids w
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    hich leads to the suffering of patients has led to the development of guidelines for pain treatment. This may help bring an end to under prescribing, but alternative forms of pain control are still necessary. NIDA-funded scientists consta
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ntly search for new ways to control pain and to develop new pain medications that are as effective as the drugs we use today but do not have the draw back of a potential addiction.

    Assessing Prescription Drug Abuse: Four Simple Questions
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi


    ●Have you ever felt the need to cut down on your use of prescription drugs?

    ●Have you ever felt annoyed by remarks your friends or loved ones made about your use of prescription drugs?

    ●Have you ever felt guilty or
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    remorseful about your use of prescription drugs?

    ●Have you ever used prescription drugs as a way to "get going" or to "calm down?"

    Role and Responsibilities of Patients

    There are many ways that patients can help prevent prescrip
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    tion drug abuse.

    ●When visiting the doctor, provide a complete medical history and a description of the reason for the visit to ensure that the doctor understands the Complaint and can prescribe appropriate medication.

    ●If a
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    doctor prescribes medicine, follow the directions for use carefully and learn about the effects that the drug could have, especially during the first few days during which the body is adapting to the medication.

    ●Be aware of the p
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    otential interactions with other drugs.

    ●Do not increase or decrease doses or abruptly stop taking a drug without consulting a health care provider first.

    ●Never use another person's prescription.

    Role and responsibilities
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    Of Pharmacists

    Pharmacists can prevent prescription drug misuse and abuse by:

    ●Explaining how to take medication properly.

    ●Informing the patient about the effects the medication may have.

    ●Providing advice about any
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    possible drug interactions.

    They can also help prevent prescription fraud or diversion by looking for false or altered prescriptions.

    Role and responsibilities of Health Care Providers

    Health care providers not only prescribe needed m
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    edications appropriately, but also:

    ● Identify prescription drug abuse when it exists.

    ● Help the patient recognize the problem.

    ● Set goals for recovery, and seek appropriate treatment such as Drug Rehab when necessa
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ry.

    Screening for any type of substance abuse can be integrated into regular history taking with questions about what prescriptions and over-the-counter drugs the patient is using and why. Screening also can be performed if a patient pre
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    sents themselves with specific symptoms associated with the abuse of a substance.

    Over time, an indication of the development of tolerance can be seen in a rapid increase in the amount of a drug needed or frequent requests for refills be
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    fore the quantity prescribed should have been used. Providers should note these changes immediately and they should also be alert to the fact that those addicted to prescription medications may engage in "doctor shopping," moving from pro
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    vider to provider in an effort to get multiple prescriptions for the drug they abuse. Preventing or halting prescription drug abuse is an important part of patient care. However, health care providers should not avoid prescribing painkill
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ers, if they are required.

    This article was put together with the help of Narconon. Narconon is a non-profit drug rehab program dedicated to eliminating drug abuse and drug addiction through drug prevention, education and rehabilitation.


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.advicepool.org.ua/article/243107/advicepool-Preventing-Abuse-of-Prescription-Drugs-and-Pain-Medications.html">Preventing Abuse of Prescription Drugs and Pain Medications</a>

    BB link (for phorums):
    [url=http://www.advicepool.org.ua/article/243107/advicepool-Preventing-Abuse-of-Prescription-Drugs-and-Pain-Medications.html]Preventing Abuse of Prescription Drugs and Pain Medications[/url]

    Related Articles:

    How to Multiply Business Sales by Up to 9 Times in Just One Week--Define the Customer Value

    The O J Simpson Case - The Impact of Race Communications - Nu Leadership Series

    Easy Entrepreneurship -- Work at Home Ideas

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com